Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Kuehn BM
  • MESH
  • Angioplasty, Balloon
  • Central Nervous System
  • Evidence-Based Medicine
  • Humans
  • Iron
  • Multiple Sclerosis
  • Stents
  • United States
  • United States Food and Drug Administration
  • Venous Insufficiency

Unbound MEDLINE

FDA warns about the risks of unproven surgical therapy for multiple sclerosis.

Links

  • Publisher Full Text
  • Authors

    Kuehn BM

    Source

    JAMA : the journal of the American Medical Association 307:24 2012 Jun 27 pg 2575-6

    MeSH

    Angioplasty, Balloon
    Central Nervous System
    Evidence-Based Medicine
    Humans
    Iron
    Multiple Sclerosis
    Stents
    United States
    United States Food and Drug Administration
    Venous Insufficiency

    Pub Type(s)

    News

    Language

    eng

    PubMed ID

    22735405

    Related Citations

    • [Cerebrospinal venous insufficiency as a cause of MS weakly supported. Unreasonable to offer balloon dilatation therapy now].
    • The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
    • Vascular angioplasty for ms?
    • Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?
    • ["Chronic cerebrospinal venous insufficiency" in multiple sclerosis - is multiple sclerosis a disease of the cerebrospinal venous outflow system?].
    • [Endovascular surgery as treatment for multiple sclerosis].
    • Face, brain, and veins: a new perspective for multiple sclerosis onset.
    • Vascular intervention for multiple sclerosis.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved